Clinical Trial Update: Study of Bendamustine, Velcade and Dexamethasone in the Treatment of Elderly Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bendamustine, bortezomib (Velcade), and dexamethasone in elderly patients with multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bendamustine (Bendamustine)
• DEXAMETHASONE (Dexamethasone)
• Velcade (bortezomib)

Snippet

Sponsor: Intergroupe Francophone du Myelome | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED